BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2198363)

  • 1. [Studies on the intraglomerular distribution of fibronectin in IgA nephropathy--in relation to clinical pictures and prognosis].
    Urae M
    Nihon Jinzo Gakkai Shi; 1990 Apr; 32(4):389-99. PubMed ID: 2198363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and clinical implication of platelet-derived growth factor-D and platelet-derived growth factor-beta in childhood IgA nephropathy].
    Rong ZH; Wang C; Hao J; Duan HJ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 May; 20(5):275-8. PubMed ID: 18471357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical use of serum beta-2-microglobulin and fractional beta-2-microglobulin excretion in IgA nephropathy.
    Lai KN; Lai FM; Vallance-Owen J
    Clin Nephrol; 1986 May; 25(5):260-5. PubMed ID: 3522000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunohistochemical analysis of extracellular components on the glomerular sclerosis in patients with glomerulonephritis and diabetic nephropathy].
    Funabiki K
    Nihon Jinzo Gakkai Shi; 1989 Jan; 31(1):111-20. PubMed ID: 2664290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Distribution of fibronectin in kidney of IgA nephropathy and its clinicopathological correlation].
    Shi Y; Li L; Zhou H
    Zhonghua Nei Ke Za Zhi; 1997 Jun; 36(6):390-3. PubMed ID: 10374298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [IgA nephropathy and Henoch-Schönlein purpura nephritis: clinicopathological, histopathological immunohistological, and electronmicroscopical characteristics].
    Hamada K
    Hokkaido Igaku Zasshi; 1984 Jul; 59(4):456-70. PubMed ID: 6386639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraglomerular distribution of fibronectin in primary glomerular diseases.
    Ikeya M; Nagase M; Honda N
    Clin Nephrol; 1985 Aug; 24(2):53-9. PubMed ID: 3899436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunofluorescent studies on alpha 2-plasmin inhibitor (alpha 2-PI) in glomeruli from patients with IgA nephropathy.
    Miura M; Tomino Y; Yagame M; Endoh M; Suga T; Nomoto Y; Sakai H
    Clin Exp Immunol; 1985 Nov; 62(2):380-6. PubMed ID: 2935337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vitronectin in children with renal disease--1. Immunofluorescence study of vitronectin and C5b-9 in childhood IgA nephropathy].
    Takahashi T; Inaba S; Okada T
    Nihon Jinzo Gakkai Shi; 1995 Apr; 37(4):213-23. PubMed ID: 7541480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum IgA-fibronectin complex in children with various renal diseases].
    Sakai Y; Inaba S; Matsukura H; Okada T
    Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1130-6. PubMed ID: 7815745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunofluorescent studies on IgA nephropathy: type IV collagen and glomerular basement membrane component detected by Goodpasture's syndrome serum and laminin.
    Tomino Y; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1988 Aug; 13(3):137-43. PubMed ID: 3075823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoelectron microscopic studies of immune complex deposits and basement membrane components in IgA nephropathy.
    Woodrow DF; Shore I; Moss J; Gower P; Phillips M
    J Pathol; 1989 Jan; 157(1):47-57. PubMed ID: 2921666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical studies of glomerular extracellular components in repeated renal biopsies of patients with IgA nephropathy.
    Funabiki K; Tomino Y; Koide H
    Nihon Jinzo Gakkai Shi; 1991 Sep; 33(9):831-7. PubMed ID: 1774839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological study on the relationship between appearance of type I or III collagen in IgA nephropathy].
    Ozu H
    Nihon Jinzo Gakkai Shi; 1992 Jun; 34(6):647-56. PubMed ID: 1479705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathological and morphometrical analysis of 5 cases from 4 families of fibronectin glomerulopathy].
    Uesugi N; Katafuchi R; Taguchi H; Turu M; Sakata N; Takebayashi S
    Nihon Jinzo Gakkai Shi; 1999 Apr; 41(2):49-59. PubMed ID: 10361419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of tissue type plasminogen activator in the glomeruli of patients with IgA nephropathy.
    Garcia G; Miura M; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1989 Apr; 14(2):131-7. PubMed ID: 2517871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice.
    Zheng F; Kundu GC; Zhang Z; Ward J; DeMayo F; Mukherjee AB
    Nat Med; 1999 Sep; 5(9):1018-25. PubMed ID: 10470078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular deposition of complex-forming glycoprotein heterogenous in charge (protein HC) in IgA nephropathy.
    Imai H; Wakui H; Ishino T; Komatsuda A; Nakamoto Y; Miura AB; Kobayashi R
    Clin Nephrol; 1992 Apr; 37(4):169-76. PubMed ID: 1374693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical studies of extracellular matrix components and integrins in IgA nephropathy.
    Kanahara K; Yorioka N; Arita M; Ohira N; Yamakido M
    Nephron; 1994; 66(1):29-37. PubMed ID: 7509047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse proliferative lupus glomerulonephritis. Determination of prognostic significance of clinical, laboratory and pathologic factors.
    Magil AB; Ballon HS; Chan V; Lirenman DS; Rae A; Sutton RA
    Medicine (Baltimore); 1984 Jul; 63(4):210-20. PubMed ID: 6377004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.